Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies

PURPOSE: Octreotide (OCT) has been successfully used for treatment of acromegaly and neuroendocrine tumors for more than 30 years. However, long-term safety of OCT has not been documented in placebo-controlled setting. This present analysis pooled safety data from two similarly-designed, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales: Pivonello, Rosario, Muscogiuri, Giovanna, Holder, Geoffrey, Paul, Michaela, Sarp, Severine, Lesogor, Anastasia, Jordaan, Pierre, Eisinger, Johannes, Colao, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845597/
https://www.ncbi.nlm.nih.gov/pubmed/29116540
http://dx.doi.org/10.1007/s12020-017-1448-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845597/
https://www.ncbi.nlm.nih.gov/pubmed/29116540
http://dx.doi.org/10.1007/s12020-017-1448-5

Ejemplares similares